Morphological features following G-CSF treatment

Haematologica

Volumn 82, Issue 4, 1997, Pages 504-505

  Azzarà, Antonio ^a,b   Carulli, Giovanni ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

APLASTIC ANEMIA; ARTICLE; BLOOD DISEASE; BLOOD SMEAR; ERYTHROCYTE MEMBRANE; NEUTROPENIA;

BLOOD CELLS; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOLOGIC DISEASES; HUMANS;

EID: 0031437023     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Locatelli F, Pedrazzoli P. Recombinant human G-CSF: how wide is the field of clinical applicability? Haematologica 1995; 80:199-205.
2. Carulli G, Minnucci S, Azzara A, et al. Granulocyte colony-stimulating factor (G-CSF) administration increases PMN CD32 (FCRII) expression and FcR-related functions. Haematologica 1995; 80: 150-4.
3. Kerrigan DP, Castillo A, Foucar K, Townsend K, Neidhart J. Peripheral blood morphologic changes after high-dose antineoplastic chemotherapy and recombinant human granulocyte colony stimulating factor administration. Am J Clin Patnol 1989; 92:280-5.
4. Hirota M, Kadota JI, Tomoto K, et al. Studies on defence effects of recombinant human granulocyte colony stimulating factor (G-CSF) to infections. 1: Induction of neutrophil polarization by G-CSF. J Jpn Assoc Infect Dis 1990; 64:425-9.
5. Azzarà A, Chimenti M, Azzarelli L, Fantini E, Carulli G, Ambrogi F. An image processing workstation for automatic evaluation of human granulocyte motility. J Immunol Meth 1992; 148:29-40.
6. Azzarà A, Chimenti M, Carulli G, Rizzuti-Gullaci A, Ambrogi F. An image processing procedure for the assessment of normality curves of motility of human granulocytes in micropore filters. Scand J Clin Lab Invest 1995; 55:399-408.
7. Azzarà A, Carulli G, Rizzuti-Gullaci A, Minnucci S, Capochiani E, Ambrogi F. Motility of rhG CSF-induced neutrophils in patients undergoing chemotherapy: evidence for inhibition detected by image analysis. Br J Haematol 1996; 92:161-8.
8. Wilkinson PC, Allan RB. Assays systems for measuring leukocyte. chemotaxis: an overview. In: Gallin JI, Quie PG, eds. Leukocyte chemotaxis: Methods, Physiology, and Clinical Implication. New York: Raven Press, 1978. p. 1-24.
9. Miller ME. Cell elastimetry in the characterization of normal and abnormal PMN movements. In: Gallin JI, Quie PG, eds. Leukocyte chemotaxis: methods, physiology, and clinical implication. New York: Raven Press, 1978. p. 379-87.
10. Price TH, Chatta GS, Dale DC. Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood 1996; 88:335-40.